A subfertile patient diagnosed with testicular carcinoma in situ by immunocytological staining for AP-2γ in semen samples: Case report
Open Access
- 1 March 2005
- journal article
- case report
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 20 (3) , 579-582
Abstract
The incidence of testicular cancer is rising. Despite a high cure rate, efforts should be made to obtain diagnosis at the pre-invasive intratubular carcinoma in situ (CIS) stage, as the disease is potentially lethal and treatment has severe side-effects, especially regarding reproductive function. CIS diagnosis is presently only possible by a surgical biopsy of the testis. Immunocytological staining for transcription factor activator protein (AP-2γ), previously identified as a marker for neoplastic germ cells, was performed in centrifuged samples of ejaculates obtained from 104 andrological patients, including patients with testicular cancer and subfertility. Cells positive for AP-2γ were found only in semen samples from patients diagnosed a priori with testicular neoplasms and, surprisingly, in a 23 year old control subject with oligozoospermia and no symptoms of a germ cell tumour. Testicular biopsies performed during the follow-up of this patient revealed widespread CIS in one testicle, thus proving a potential diagnostic value of the new marker. For the first time, a patient without clinical symptoms of testicular neoplasia was diagnosed at the pre-invasive CIS stage using a new, simple method based on immunocytological staining of a semen sample for AP-2γ, a novel marker for CIS. The value of this method for diagnostic use in the clinic requires further careful validation in a large series of patients and controls, but the preliminary results are promising.Keywords
This publication has 12 references indexed in Scilit:
- Transcription Factor AP-2γ Is a Developmentally Regulated Marker of Testicular CarcinomaIn situand Germ Cell TumorsClinical Cancer Research, 2004
- Embryonic Stem Cell-Like Features of Testicular Carcinomain SituRevealed by Genome-Wide Gene Expression ProfilingCancer Research, 2004
- Increasing Incidence of Testicular Cancer Worldwide: A ReviewJournal of Urology, 2003
- Carcinoma in situ in the TestisScandinavian Journal of Urology and Nephrology, 2000
- Fluorescencein situ hybridization analysis of chromosome 12 anomalies in semen cells from patients with carcinomain situ of the testisThe Journal of Pathology, 1998
- Detection and enrichment of carcinoma-in-situ cells in semen by an immunomagnetic method using monoclonal antibody M2AInternational Journal of Andrology, 1996
- A monoclonal antibody as a marker for carcinoma in situ germ cells of the human adult testisAPMIS, 1988
- CARCINOMA-IN-SITU GERM-CELLS EXFOLIATED FROM SEMINIFEROUS EPITHELIUM INTO SEMINAL FLUIDThe Lancet, 1988
- Detection of Testicular Neoplasms by Cytological Examination of Seminal FluidJournal of Urology, 1987
- POSSIBLE CARCINOMA-IN-SITU OF THE TESTISThe Lancet, 1972